TARO-APIXABAN
Active Ingredient: APIXABAN
Product Overview
About TARO-APIXABAN
TARO-APIXABAN is a medication that contains the active ingredient APIXABAN, which is a factor Xa inhibitor used to prevent and treat blood clots. It is primarily prescribed for patients at risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as those with atrial fibrillation not caused by heart valve problems. TARO-APIXABAN works by reducing the formation of blood clots, thereby reducing the risk of stroke and other cardiovascular events.
Key Benefits & Uses
- Prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing hip or knee replacement surgery
- Treatment of DVT and PE
- Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation
Active Ingredient & Action
APIXABAN, the active ingredient in TARO-APIXABAN, works by selectively inhibiting factor Xa, a critical component in the coagulation cascade. This inhibition reduces the formation of blood clots, thereby decreasing the risk of thrombotic events. APIXABAN has a predictable pharmacokinetic profile, allowing for fixed dosing without the need for routine coagulation monitoring.
Important Notes
Patients taking TARO-APIXABAN should be aware of the increased risk of bleeding and should report any signs of bleeding to their doctor immediately. It is also important to follow the prescribed dosage and to inform your doctor about any other medications you are taking, as APIXABAN may interact with certain drugs. Regular monitoring by a healthcare professional is necessary to minimize the risk of adverse effects and ensure the safe use of TARO-APIXABAN.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.